echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Over 200 million euros! Does human "second genome" have the potential to treat tumor?

    Over 200 million euros! Does human "second genome" have the potential to treat tumor?

    • Last Update: 2020-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, venture partners, a French based venture capital firm, announced at the bio Europe conference that its financing activities in the field of microbiomics and nutrition are still continuing With the increasing interest of many industries in the field of microbiome, the total amount of this financing will increase to nearly 250 million euros from 200 million euros (220 million US dollars) published in March last year This fund is the second exclusive fund launched by venture for the field of microbiome At the end of 2014, venture launched the first life and health fund focusing on microbiome, and completed the investment in the middle of last year, with a total asset of 160 million euros According to seven, the therapeutic space of microbiomics will mature in the next three years So let's first understand what microbiome is Microbiome refers to all microorganisms in and out of the body, including bacteria, fungi, viruses, etc There are thousands of microorganisms in human intestine, which constitute the main body of human microbiome In the human body, the number of microorganisms is about 10 times that of human cells, while the number of microbial genes is more than 100 times that of human genes The ecosystem of human microbiome affects many biological processes, which makes its balance very important for human health Understanding and maintaining the balance of this complex ecosystem is one of the important goals of future medical progress It provides opportunities for drug development, especially in the prevention and treatment of chronic diseases At present, microbiology is one of the new fields of rapid development in the field of medicine and nutrition According to the statistics of venture, in 2018 alone, more than 2400 clinical trials based on microbiological validation of treatment methods have been carried out, and the number is still growing rapidly Ms Isabelle de cremous, chief executive officer of venture, said that while microbiome could have an impact in all of these areas, it has great potential in oncology from a market perspective Although some microorganisms will reduce the effect of anticancer drugs, there are other microorganisms that are necessary to make these drugs work This means that having the right microbiome can greatly affect the survival rate of cancer patients Source: reference [1] Mr Eric de la fortelle, the risk partner of the company, said that at present, not only the pharmaceutical companies showed strong interest in microbiome, but also the nutrition and health products, animal health companies and other companies showed increasing interest in microbiome In the field of nutrition and health care products, the products that claim to affect intestinal flora are everywhere and relatively abundant Although reliable data from the academic community continue to emerge, a more standardized and effective therapeutic microbiome product is still in its infancy "Until we get the results of phase 2B / 3 clinical trials and get the first product on the market, we will still be in the development stage of microbiome products," said Eric de la fortelle, partner of venture capital "At present, researchers are still looking for appropriate clinical development strategies and market expansion strategies, which may take another two to three years to mature."
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.